Literature DB >> 29197584

Depletion of transglutaminase 2 in neurons alters expression of extracellular matrix and signal transduction genes and compromises cell viability.

Laura Yunes-Medina1, Alex Paciorkowski2, Yan Nuzbrokh3, Gail V W Johnson4.   

Abstract

The protein transglutaminase 2 (TG2) has been implicated as a modulator of neuronal viability. TG2's role in mediating cell survival processes has been suggested to involve its ability to alter transcriptional events. The goal of this study was to examine the role of TG2 in neuronal survival and to begin to delineate the pathways it regulates. We show that depletion of TG2 significantly compromises the viability of neurons in the absence of any stressors. RNA sequencing revealed that depletion of TG2 dysregulated the expression of 86 genes with 59 of these being upregulated. The genes that were upregulated by TG2 knockdown were primarily involved in extracellular matrix function, cell signaling and cytoskeleton integrity pathways. Finally, depletion of TG2 significantly reduced neurite length. These findings suggest for the first time that TG2 plays a crucial role in mediating neuronal survival through its regulation of genes involved in neurite length and maintenance.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell survival; Neurite length; Neurons; RNA sequencing; Transglutaminase

Mesh:

Substances:

Year:  2017        PMID: 29197584      PMCID: PMC5736014          DOI: 10.1016/j.mcn.2017.11.011

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  38 in total

1.  Transglutaminase 2 protects against ischemic stroke.

Authors:  A J Filiano; J Tucholski; P J Dolan; G Colak; G V W Johnson
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

Review 2.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

3.  Involvement of the plasminogen enzymatic cascade in the reaction to axotomy of rat sympathetic neurons.

Authors:  M Egle De Stefano; Lucia Leone; Claudia Moriconi; Arianna Del Signore; Tamara C Petrucci; Paola Paggi
Journal:  Mol Cell Neurosci       Date:  2007-07-18       Impact factor: 4.314

4.  Mechanism of allosteric regulation of transglutaminase 2 by GTP.

Authors:  Gillian E Begg; Lyle Carrington; Philippa H Stokes; Jacqueline M Matthews; Merridee A Wouters; Ahsan Husain; Laszlo Lorand; Siiri E Iismaa; Robert M Graham
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-18       Impact factor: 11.205

5.  Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia.

Authors:  Laura Yunes-Medina; Julianne Feola; Gail V W Johnson
Journal:  Neuroreport       Date:  2017-12-13       Impact factor: 1.837

6.  Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury.

Authors:  Julianne Feola; Alan Barton; Abdullah Akbar; Jeffrey Keillor; Gail V W Johnson
Journal:  Brain Res       Date:  2017-05-15       Impact factor: 3.252

7.  Inhibition or ablation of transglutaminase 2 impairs astrocyte migration.

Authors:  Alina Monteagudo; Changyi Ji; Abdullah Akbar; Jeffrey W Keillor; Gail V W Johnson
Journal:  Biochem Biophys Res Commun       Date:  2016-11-27       Impact factor: 3.575

8.  Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration?

Authors:  Miriam E van Strien; Benjamin Drukarch; John G Bol; Paul van der Valk; Jack van Horssen; Wouter H Gerritsen; John J Breve; Anne-Marie van Dam
Journal:  Brain Pathol       Date:  2010-08-20       Impact factor: 6.508

Review 9.  Tissue transglutaminase: an enzyme with a split personality.

Authors:  J S Chen; K Mehta
Journal:  Int J Biochem Cell Biol       Date:  1999-08       Impact factor: 5.085

10.  Tissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway.

Authors:  Santosh Kumar; Kapil Mehta
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

View more
  5 in total

Review 1.  Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.

Authors:  Breandan R Quinn; Laura Yunes-Medina; Gail V W Johnson
Journal:  J Neurosci Res       Date:  2018-03-23       Impact factor: 4.164

2.  Naturally Occurring Epsilon Gamma Glutamyl Lysine Isopeptide Crosslinks in Human Neuroblastoma SH-SY5Y Cells.

Authors:  Oksana Lockridge; Lawrence M Schopfer
Journal:  ACS Omega       Date:  2022-06-16

3.  Deletion or Inhibition of Astrocytic Transglutaminase 2 Promotes Functional Recovery after Spinal Cord Injury.

Authors:  Anissa Elahi; Jacen Emerson; Jacob Rudlong; Jeffrey W Keillor; Garrick Salois; Adam Visca; Peter Girardi; Gail V W Johnson; Christoph Pröschel
Journal:  Cells       Date:  2021-10-29       Impact factor: 6.600

4.  The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer's Disease.

Authors:  Micha M M Wilhelmus; Elisa Tonoli; Clare Coveney; David J Boocock; Cornelis A M Jongenelen; John J P Brevé; Elisabetta A M Verderio; Benjamin Drukarch
Journal:  Cells       Date:  2022-01-24       Impact factor: 6.600

5.  Comparative Profiling of TG2 and Its Effectors in Human Relapsing Remitting and Progressive Multiple Sclerosis.

Authors:  Damien D Pearse; Andrew B Hefley; Alejo A Morales; Mousumi Ghosh
Journal:  Biomedicines       Date:  2022-05-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.